Pharmaceuticals and healthcare
In the recent years, the pharmaceuticals and healthcare companies face increasing competition and tighter regulation. Jinga, Maravela & Asociații’s broad experience and technical understanding of the national and regional pharmaceuticals, medical devices and healthcare services markets enable us to render focused, integrated and cost-effective solutions to our clients.
Lawyers handling our pharmaceuticals and healthcare practice have acquired massive expertise in advising a large number of pharmaceutical and biotechnology companies and medical devices manufacturers, including nine of the largest companies worldwide, as well as healthcare services providers, regulators and professional associations with regard to a plethora of matters spanning from regulatory, cross-border mergers, acquisitions and re-organisations, intellectual property rights, advertising, taxation, employment, litigation and arbitration, insolvency, competition, interactions with government officials and doctors, sponsorships, pricing, clinical and non-interventional trials.
This information was sourced from the Jinga Maravela website.
Briefings from Jinga Maravela
Jinga Maravela has released the October issue of its Tax Newsletter, which includes amendments to the content of Form 100 and clarifications on the additional taxation for management severance payments.
Jinga Maravela has released the September issue of its Tax Newsletter, which includes amendments to the Fiscal Procedural Code and amendments to the contributions due to the Environmental Fund.